BHC

BHC's income statement finally turned the corner: FY2025 revenue of $10.3B (+6.7% YoY) capped a four-year recovery from $8.12B, operating income rose to $1.81B (+17.3%), and the company posted its first GAAP profit of the cycle — net income of $157M and diluted EPS of $0.42 versus a string of losses ($948M, $225M, $592M, $46M from FY2021-FY2024). Operating cash flow of $1.40B against $397M capex leaves real free cash flow. On the surface the stock screens cheap at 11.5x earnings and 0.2x sales. That optical cheapness is the trap, not the thesis.

The balance sheet is the entire story. Stockholders' equity is NEGATIVE $554M, retained earnings are a $9.67B accumulated deficit, and long-term debt stands at $20.6B against just $1.31B of cash. The equity isn't a claim on a healthy business — it's a residual stub sitting behind ~$20.2B of contractual principal. Adjusting for that, enterprise value is roughly $21B (market cap $1.80B + debt − cash), so the company trades near 12x EV/operating-income — fully valued, not cheap, once the debt is counted. Net margin of just 1.5% shows how little of that $10.3B in revenue survives the interest load.